4886 — ASKA Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00Table: Aska Pharmaceutical -2020/21 group forecast
Table: Aska Pharmaceutical - 9-MTH group results
Table: Aska Pharmaceutical - 6-MTH group results
Table: Aska Pharmaceutical -Q1 group results
Table: Aska Pharmaceutical -2019/20 group results
Table: Aska Pharmaceutical -2019/20 group forecast
Table: Aska Pharmaceutical -2019/20 div forecast
Table: Aska Pharmaceutical - 9-MTH group results
Table: Aska Pharmaceutical - 6-MTH group results
Table: Aska Pharmaceutical -Q1 group results
Table: Aska Pharmaceutical -2018/19 group results
To Transfer 216,600 Own Shares To Employee Trust Fund In Third-Party Allocation At 1,126 Yen/Share, On March 4
Table: Aska Pharmaceutical - 9-MTH group results
Table: Aska Pharmaceutical -2018/19 group forecast
Table: Aska Pharmaceutical - 6-MTH group results
Table: Aska Pharmaceutical -Q1 group results
2018 6-month group forecast
Brief: ASKA Pharmaceutical says voluntary recall of hypertension treatment drug valsartan
Brief: Takeda Pharmaceutical and ASKA Pharmaceutical enter into licensing agreement for relugolix in women's health indications